ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Zhou Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1098-1135; OpenAlex author ID A5044481155. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper

Papers 1

Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.20892/j.issn.2095-3941.2023.0189 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui Jun Tang · 1 shared paper, 2023 · strength 0.20
- Paper Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic … DOI 10.20892/j.issn.2095-3941.2023.0189 ↗
Yingyi Wang · 1 shared paper, 2023 · strength 0.20
- Paper Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic … DOI 10.20892/j.issn.2095-3941.2023.0189 ↗
Yuejuan Cheng · 1 shared paper, 2023 · strength 0.20
- Paper Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic … DOI 10.20892/j.issn.2095-3941.2023.0189 ↗
Chunmei Bai · 1 shared paper, 2023 · strength 0.20
- Paper Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic … DOI 10.20892/j.issn.2095-3941.2023.0189 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.